保法止品牌怎么样 申请店铺

我要投票 保法止在生发行业中的票数:665 更新时间:2025-07-06
保法止是哪个国家的品牌?「保法止」是默沙东(中国)投资有限公司旗下著名品牌。该品牌发源于美国,由创始人JOSEPH SHADS ROMANELLI在2012-02-22期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力保法止品牌出海!将品牌入驻外推网,定制保法止品牌推广信息,可以显著提高保法止产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

保法止怎么样

保法止是唯一经过美国FDA认证治疗男性脱发的非那雄胺药物。保法止主要成分为非那雄胺,它是一种合成的甾体化合物,是雄激素睾酮代谢成为双氢睾酮过程中的细胞内酶Ⅱ型5a还原酶的特异性抑制剂,通过对该酶的抑制,使得患者头皮以及血清中的双氢睾酮浓度下降,从而抑制头皮毛囊变小,逆转脱发过程。保法止是一种专门用于治疗雄激素性秃发(男性秃发),能有效促进头发生长并防止继续脱发的内服药物。

默沙东公司是世界著名的跨国制药企业,总部设于美国新泽西州(在美国名为默克公司),全球雇员超过83,000人。默沙东以科研为本,致力于医学研究、开发和销售人用及兽用医药产品,其行销网络遍及美国、欧洲、中南美洲以及亚太共70个国家和地区,设有31家工厂及17个物流发货中心,目前在全球生产及销售的默沙东产品已有150多种,2007年销售额242亿美元。其2012年收入为473亿美元,同年的研发支出为81.68亿美元。

2009年3月9日,默沙东宣布将以411亿美元,并购其竞争对手先灵葆雅,两家公司在一则联合声明中公布了以上消息,合并后的公司将沿用默沙东公司的名称。默沙东总裁、首席执行官理查德?克拉克(RichardT.Clark)将负责领导新公司。并购支付方式为现金加股票,并购后默沙东将成为全美第二大制药公司。

1992年默沙东(中国)有限公司正式成立。1994年,默沙东与杭州华东医药集团有限公司成立了合资企业——杭州默沙东制药有限公司。默沙东在中国市场主要销售17个产品,其中大部分产品已在杭州工厂分装或生产。产品覆盖领域广泛,在降血压、调节血脂、治疗前列腺增生、哮喘、骨关节炎、骨质疏松、男性脱发和艾滋病等多个治疗领域方面均居领先地位。还有一系列疫苗预防甲肝、麻疹风疹腮腺炎及肺炎球菌、流感嗜血杆菌引起的疾病。目前默沙东在中国已有员工4500余名,在全国设有14个办事处,在未来默沙东中国还将继续扩大自己的员工队伍,并制定了“制胜中国”的宏伟计划,寄望在中国市场取得匹配其全球制药巨头地位的成绩。

Baofazhi is the only finasteride drug certified by FDA to treat male hair loss. Finasteride is the main component of baofazhi, which is a synthetic steroid compound. It is a specific inhibitor of intracellular enzyme type Ⅱ 5A reductase in the process of androgen testosterone metabolizing into dihydrotestosterone. Through the inhibition of this enzyme, the concentration of dihydrotestosterone in patients' scalp and serum is decreased, so as to inhibit the hair follicle of scalp to become smaller and reverse the hair loss process. Baofazhi is a kind of internal medicine specially used to treat androgenic alopecia (male alopecia), which can effectively promote hair growth and prevent hair loss. Merck is a world-famous multinational pharmaceutical company, headquartered in New Jersey (Merck in the United States), with more than 83000 employees worldwide. Based on scientific research, MSD is committed to medical research, development and sales of human and veterinary medical products. Its marketing network covers 70 countries and regions in the United States, Europe, central and South America and Asia Pacific. It has 31 Factories and 17 logistics and delivery centers. Currently, there are more than 150 kinds of MSD products produced and sold in the world, with a sales volume of US $24 billion 200 million in 2007. Its revenue in 2012 was US $47.3 billion, and its R & D expenditure in the same year was US $8.168 billion. On March 9, 2009, MSD announced that it would acquire its competitor Schering plough for us $41.1 billion. The two companies announced the above information in a joint statement. The merged company will use the name of MSD. Richard T. Clark, President and chief executive of MSD, will lead the new company. The payment method of M & A is cash plus stock. After M & A, MSD will become the second largest pharmaceutical company in the United States. In 1992, MSD (China) Co., Ltd. was officially established. In 1994, MSD and Hangzhou Huadong Pharmaceutical Group Co., Ltd. established a joint venture - Hangzhou MSD Pharmaceutical Co., Ltd. MSD mainly sells 17 products in the Chinese market, most of which have been repackaged or produced in Hangzhou factory. The products cover a wide range of fields, and take the leading position in many fields, such as lowering blood pressure, regulating blood lipid, treating prostatic hyperplasia, asthma, osteoarthritis, osteoporosis, male hair loss and AIDS. There are also a series of vaccines to prevent diseases caused by hepatitis A, measles, rubella, mumps, pneumococcus and Haemophilus influenzae. At present, MSD has more than 4500 employees in China and has 14 offices across the country. In the future, MSD China will continue to expand its staff and develop a grand plan of "winning China", hoping to achieve results matching its position as a global pharmaceutical giant in the Chinese market.

本文链接: https://brand.waitui.com/521bbf9e3.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

斯迪克:公司OCA产品在三星供应链的合作暂未批量供货

36氪获悉,斯迪克在互动平台表示,目前公司的OCA产品在三星供应链的相关合作尚处于样品测试评估阶段,暂未形成批量供货。

2小时前

盘古团队最新声明:严格遵循开源要求

36氪获悉,7月5日下午,华为诺亚方舟实验室在官方平台发布最新声明称,盘古Pro MoE开源模型是基于昇腾硬件平台开发、训练的基础大模型,并非基于其他厂商模型增量训练而来。上述团队表示,“盘古Pro MoE开源模型部分基础组件的代码实现参考了业界开源实践,涉及其他开源大模型的部分开源代码。我们严格遵循开源许可证的要求,在开源代码文件中清晰标注开源代码的版权声明。这不仅是开源社区的通行做法,也符合业界倡导的开源协作精神。”

2小时前

顺德农商行撤回IPO申请

7月4日,深交所发行上市审核信息公开网站显示,因广东顺德农村商业银行股份有限公司、保荐人撤回发行上市申请,深交所决定终止其发行上市审核。截至目前,处于A股上市“候场区”的银行仅剩5家,分别是湖州银行、江苏昆山农商银行、湖北银行、广东南海农商银行、东莞银行,其中仅湖州银行处于“已问询”状态。(界面)

2小时前

美团即时零售日订单突破1亿,较去年峰值提前33天

7月5日晚,美团向内部员工推送的战报显示,截至20时45分,美团即时零售日订单量突破1亿单。今年美团订单峰值比去年提前了33天,去年8月7日美团日订单超过了9000万。据媒体报道,今年6月以来美团的日订单连续保持在9000万以上。这一峰值是在外卖迎来激烈竞争的局面下取得的。在这次的内部战报中,美团多次提及了“用户体验”,强调“继续为用户创造最佳体验”。

2小时前

美团即时零售日订单已突破1.2亿,餐饮订单占比过亿

据美团内网公布信息显示,截至22时54分,美团即时零售当日订单已经突破了1.2亿单,其中,餐饮订单已超过1亿单。值得注意的是,就在当晚20时45分,美团内网曾显示即时零售日订单突破了1亿。这也意味着,在2个小时的时间内,美团已产生了超过2000万笔订单。考虑到周末夜宵时段仍然是外卖高峰期,这一数据目前仍在增长中。7月5日是暑期消费旺季正式开启后的第一个周末,也是外卖消费的传统促销季。公开报道显示,去年夏天美团的订单峰值超过了9000万单。

2小时前

本页详细列出关于保法止的品牌信息,含品牌所属公司介绍,保法止所处行业的品牌地位及优势。
咨询